Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab
Casper Steenholdt, Jørn Brynskov, Ole Ø Thomsen, Lars K Munck, Jan Fallingborg, Lisbet A Christensen, Gitte Pedersen, Jens Kjeldsen, Bent A Jacobsen, Anne Sophie Oxholm, Jakob Kjellberg, Klaus Bendtzen, Mark A Ainsworth
Dive into the research topics of 'Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab'. Together they form a unique fingerprint.